Status:
COMPLETED
Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy
Lead Sponsor:
Yonsei University
Conditions:
Renal Mass
Eligibility:
All Genders
20-79 years
Phase:
NA
Brief Summary
Ulinastatin reduces systemic inflammatory responses and protects organs from ischemia/reperfusion-induced injury. The aim of this study is to evaluate the effect of ulinastatin on postoperative renal ...
Eligibility Criteria
Inclusion
- patients who are scheduled to undergo robot-assisted laparoscopic partial nephrectomy with an American Society of Anesthesiologists (ASA) physical status I-III
Exclusion
- Subjects are ineligible if they have severe respiratory or cardiovascular disease, renal insufficiency before operation, cognitive dysfunction, are unable to communicate or speak Korean
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT02258906
Start Date
October 1 2014
End Date
July 1 2016
Last Update
August 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea